BioLineRx Ltd (BLRX): BioLineRx Ltd. (BLRX) is a clinical-stag...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	144
Posts	27707
Boards Moderated	3
Alias Born	02/07/2004

midastouch017

Re: None

Tuesday, 08/01/2017 9:41:40 AM

Tuesday, August 01, 2017 9:41:40 AM

BioLineRx Ltd. (BLRX) is a clinical-stage biopharmaceutical company focused on oncology and immunology. On July 26, the company announced that its largest shareholder, BVF Partners L.P., entered into a definitive agreement to make an additional, direct investment of $9.6 million in BioLineRx. BVF's new investment is priced at $1.13 per unit. Each unit consists of 1 ordinary share, 0.35 of a Series A warrant, and 0.35 of a Series B warrant. "BioLineRx's therapeutic pipeline, strategic collaborations, scientific breadth and capabilities provide for a compelling investment opportunity for BVF. We are pleased to support the Company in the continued advancement of its clinical programs," said Mark Lampert, Founder and President of BVF Partners L.P. In early July, shares of BioLine were trading around $0.84 and on Monday, July 31, the stock saw highs of $1.09 to mark a near 30% move in 3 weeks.

https://finance.yahoo.com/news/3-biotech-stocks-watch-august-132500528.html